-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lm+Efhu61coBKEQ0uEJQVDenzVr+NS7eN9YFckPfWqxrr9FO/NAI48SVhQD7fl+O 1iyfijQ3SnH8DPybw+1D9Q== 0000891618-06-000493.txt : 20061207 0000891618-06-000493.hdr.sgml : 20061207 20061207162034 ACCESSION NUMBER: 0000891618-06-000493 CONFORMED SUBMISSION TYPE: FWP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20061207 DATE AS OF CHANGE: 20061207 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 FILING VALUES: FORM TYPE: FWP SEC ACT: 1934 Act SEC FILE NUMBER: 333-125786 FILM NUMBER: 061262892 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 FILING VALUES: FORM TYPE: FWP BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FWP 1 f25658fwfwp.htm FWP fwp
 

Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement No. 333-125786 and No. 333-138306
FINAL PRICING TERMS
December 6, 2006
     
Issuer:
  Cytokinetics, Incorporated (NASDAQ: CYTK). 
 
   
Securities Offered:
  Common Stock 
 
   
Maximum Number of Shares
  5,285,715 
 
   
Price Per Share
  $7.00 per Share 
 
   
Estimated net Proceeds
  $34.96 million 
 
   
Dilution
  Dilution per share to new investors will equal $4.20 
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively the issuer and the placement agent will arrange to send you the prospectus if you request it by calling 212-632-6717.

-----END PRIVACY-ENHANCED MESSAGE-----